Daniel Rootman, MD
Enriched profileAssociate Professor-in-Residence, Ophthalmology · University of California, Los Angeles (UCLA)
Daniel Rootman is Associate Professor-in-Residence, Ophthalmology at University of California, Los Angeles (UCLA). OpenAlex indexes 262 publications with 2,366 citations (h-index 27); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 18 Oct 2026
Daniel Rootman, MSC MD FRCSC, is Associate Professor-in-Residence, Ophthalmology at University of California, Los Angeles (UCLA). The public record shows 262 publications with 2,366 citations (h-index 27), centered on Ophthalmology and Eye Disorders, Ocular Disorders and Treatments, Ocular Oncology and Treatments. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies.
- Most recent indexed publication: 2026 · Ophthalmic plastic and reconstructive surgery
- Top research focus: Ophthalmology and Eye Disorders
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 75.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Hyaluronic Acid Gels for Lower Lid Retraction
Sponsor: University of California, Los Angeles
- Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Sponsor: University of California, Los Angeles
- Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery
Sponsor: University of Toronto
Industry payments
Updated 18 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202538 payments$36,229openpaymentsdata.cms.gov ↗
- ARGENX US, INC.Program year202521 payments$23,483openpaymentsdata.cms.gov ↗
- BIOTISSUE HOLDINGS INC.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
94.7%Neuromuscular Blocker94.7%Onabotulinumtoxina51%Incobotulinumtoxin a49%Part B, office-administered≥18 patientsAnti-infectives
3.4%Macrolide3.2%Erythromycin100%Part D≥154 patientsFirst-generation cephalosporins0.2%Cephalexin100%Part D≥13 patientsSensory organs
1.2%Aminoglycoside Antibacterial1%Neomycin-Polymyxin-Dexameth59%Tobramycin-Dexamethasone42%Part D≥31 patientsLymphocyte Function-Associated Antigen-1 Antagonist0.2%Xiidra100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Healthcare System Cost Analysis of Common Ophthalmic Procedures Performed in an Operating Room Versus an Office Procedure Room.
Ophthalmic plastic and reconstructive surgery
Article2026 - Phosphaturic Mesenchymal Tumor Originating in the Orbit.
Ophthalmic plastic and reconstructive surgery
Case Report2026 - Prevalence, Clinical and Imaging Characteristics of Superior Ophthalmic Vein Periphlebitis in Thyroid Eye Disease.
Ophthalmic plastic and reconstructive surgery
Article2024 - Hyperostosis associated with orbital vascular malformation.
Orbit (Amsterdam, Netherlands)
Article2024
Most-cited works
by citation count (OpenAlex)- 01Orbital decompression for thyroid eye diseaseArticle115 citations2017
- 02
- 03Orbital lymphaticovenous malformations: Current and future treatmentsArticle93 citations2015
- 04
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
profiles.ucla.edu/daniel.rootman/202
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucla.edu ↗ - Other
bopss.co.uk/speakers/dan-rootman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bopss.co.uk ↗ - Other
uclahealth.org/providers/daniel-rootman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Orbital Disease Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Awards & honors
honors on the public record- Super Doctors
Southern California
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Marder, MD
University of California, Los Angeles (UCLA)
Steven Cramer, MD
University of California, Los Angeles (UCLA)
Rhonda Voskuhl, MD
University of California, Los Angeles (UCLA)
Joseph Pisegna, MD
University of California, Los Angeles (UCLA)
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital